FTC files administrative complaint against the three largest PBMs
Federal Trade Commission
- Named role
- Respondent
- HHI coverage
- 0 paired / 1
Exact official-record label
Emisar Pharma Services LLC
Group purchasing organization named in the FTC insulin administrative complaint record.
Exact source label, not a standalone legal-entity, ownership, liability, or market-power determination.
Official labelEmisar Pharma Services LLC
Policy organizationEmisar Pharma Services LLCOfficial label / 1 record / 2024
- Record identityExact source labelNot legal-entity resolution
- Official coverage1 dated record2024
- Market scope1 contextLinked by the official record
- Permitted useRecord tracingNot a liability finding
Official record chronology
Why this exact label appears
Sep 20, 2024
LitigationDocket Docket No. 9437
Federal Trade Commission
FTC files administrative complaint against the three largest PBMs
The FTC brought an administrative action alleging anticompetitive and unfair rebating and formulary practices involving Caremark, Express Scripts, OptumRx, and affiliated GPOs.
Named as Respondent
The FTC administrative complaint names affiliated GPO Emisar Pharma Services as a respondent.
Descriptive economic context
Public HHI evidence around each record
Each row searches the linked market profile for strict pre-event, same-year, and strict post-event observations. Missing anchors remain visible.
0Paired
0One-sided
1Unavailable
- Strict pre
- Unavailable
- No earlier HHI
- Event year
- Unavailable
- No same-year HHI
- Strict post
- Unavailable
- No later HHI
- Pre-post change
- Not available
- Pair not available
Before/after HHI differences are descriptive comparisons between discrete public releases. They do not estimate the causal effect of the policy event.
Bounded market context
Markets linked by the cited records
United States / Health care
PBMs
1 named record / 0 paired HHI windows
Respondent
A market link records the scope named by the official event. It does not establish that every named organization participates throughout that market or define a relevant antitrust market for a different matter.
Source custody
Official records behind the dossier
Federal Trade Commission / agency report
FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices
Accessed Jul 17, 2026. Federal Trade Commission, FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices, September 20 2024.
Reproducible record packet
Reuse the exact organization dossier
Filtered index and relationship routes preserve the organization slug, exact role, event ID, market context, source URL, and inference guardrails.
- Organization ID
- pent-emisar-pharma
- Profile slug
- emisar-pharma-services-llc
- Named edges
- 1
- License
- CC BY 4.0
Official-record interpretation boundary
These dossiers compile exact organization labels from official public records. They do not resolve corporate identity, ownership, control, affiliate status, liability, or market power beyond what the cited record expressly states.
A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.